Skip to main content
. 2021 Dec 25;14:5681–5698. doi: 10.2147/IDR.S338827

Figure 6.

Figure 6

Viability of lung adenocarcinoma cells (A549) upon treatment with CSA alone and with 1%, 2%, and 5% pluronic at doses of 1–50 μg/mL. CSA-13 (A), CSA-44 (B), and CSA-131 (C). Results show: mean±SD, n=3; * indicates statistical significance.